- Basic concepts
- Functional esophageal disorders
- Functional gastroduodenal disorders
- General approach to gastroduodenal disorders
- Functional dyspepsia
- Belching disorders
- Nausea and vomiting disorders
- Functional bowel disorders
- Scientific update
- Resources
- Bibliography
Search
Resources / Archives Scientific Update
Abstracts january-february
A combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria to a greater extent than Lactobacillus GG on its own.
No significant differences were seen in the amount of LGG, lactobacilli or pH. Defaecation frequency, consistency of stools or ease of defaecation did not differ between the 2 study periods. Although neither the occurrence nor the sum of gastrointestinal symptom scores was significantly different between the treatments, the intensity of flatulence was significantly greater after ingestion of both LGG and GOS (17.0 vs. 10.0, P = 0.018). Ingestion of both LGG and 2 g of GOS increased the bifidobacteria more than LGG on its own. It is suggested that GO has a prebiotic effect
Effects of a combination of Lactobacillus rhamnosus GG (LGG) and galactooligosaccharides (GOS) or LGG on its own on the intestinal microbiota were investigated. 44 healthy adults were randomised for a double-blind 2-period cross-over study. There were 2 Î 3-wk study periods with a 4-wk wash-out period in between. The subjects ingested daily milk-based fruit juice containing either LGG alone or LGG plus GOS. At the end of the study periods the amount of bifidobacteria was significantly greater after the ingestion of LGG plus GOS compared with LGG alone (9.54 vs. 9.30 log10 cfu/g, P = 0.023).